|
Specialty Laboratories, founded in 1975, is a full-service,
clinical reference laboratory focused on partnering with
hospitals to support their role in community-based medicine
and to reduce costs for episodes of care. Following their
recently completed merger with AmeriPath, Inc., Specialty
remains a distinct operating division and their 200,000
sq ft, state-of-the-art facility in Valencia, California
has become the Esoteric Testing Division Headquarters for
the newly combined organization. Specialty will continue
to provide cutting-edge research and development of new
assays as well as refinement of existing diagnostic tests
to produce assays with greater sensitivity, specificity,
efficiency and clinical value for reliable and cost-effective
patient assessment.
Together Specialty and AmeriPath are uniquely positioned
to more effectively support local pathology and community-based
medicine for enhanced patient care. Our complementary areas
of expertise and service offerings will allow us to build
on both companies' leadership positions, provide access
to each other's medical and scientific expertise, expand
our geographic presence to better serve our customers, and
become the most valued company in our industry.
The new, broader scope of Specialty now offers clients:
- A bi-coastal presence for efficient specimen handling
and delivery services
- A unified process for ordering and reporting both clinical
and anatomic pathology testing services to expedite testing
for enhanced patient care
- Additional outreach partnership solutions to help support
client hospital's growth and position in the community
- A single-source for a comprehensive menu of both clinical
and anatomic pathology laboratory services and cutting-edge
molecular diagnostics
- 24/7 Access to the clinical expertise within a network
of over 400 pathologists and clinical/technical consultants
Strategic relationships with AmeriPath Esoteric Institute,
The Center for Advanced Diagnostics and The Molecular Profiling
Institute, Inc. (MPI), a subsidiary of Translational Genomics
Research Institute (TGen), means Specialty can offer
novel molecular-based assays to help physicians treat patients
with individualized management plans. With these new genomic
assays Specialty's client-partners can utilize pathways
to personalized patient care that will help to build their
image as a leading authority within the medical community
and help position them for rapid growth.
Assays are available to support testing in a wide range
of clinical areas, including:
|
